Page last updated: 2024-11-04

sulfanilamide and Glaucoma

sulfanilamide has been researched along with Glaucoma in 8 studies

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scozzafava, A6
Briganti, F1
Mincione, G2
Menabuoni, L3
Mincione, F5
Supuran, CT6
Winum, JY1
Casini, A2
Starnotti, M2
Montero, JL1
Masini, E1
Bacciottini, L1
Scrivanti, C1
Vullo, D1
LITCHFIELD, JT1
ALONSO, L1
GODDARD, L1
PARDUCCI, F1
NUCCI, E1

Reviews

1 review available for sulfanilamide and Glaucoma

ArticleYear
Glaucoma and the applications of carbonic anhydrase inhibitors.
    Sub-cellular biochemistry, 2014, Volume: 75

    Topics: Acetazolamide; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Carbonic

2014

Other Studies

7 other studies available for sulfanilamide and Glaucoma

ArticleYear
Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
    Journal of medicinal chemistry, 1999, Sep-09, Volume: 42, Issue:18

    Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane

1999
Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.
    Bioorganic & medicinal chemistry letters, 2001, Feb-26, Volume: 11, Issue:4

    Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Glaucoma; Intraocular Pressure; Pen

2001
Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.
    Journal of medicinal chemistry, 2002, Mar-28, Volume: 45, Issue:7

    Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chelating Agents; Chloroform; Chromatog

2002
Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits.
    Bioorganic & medicinal chemistry letters, 2004, Jan-05, Volume: 14, Issue:1

    Topics: Administration, Topical; Animals; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Glaucoma;

2004
Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17

    Topics: Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Disease Models,

2005
Determination of minute quantities of sulanilamide derivatives in biological samples.
    Federation proceedings, 1946, Volume: 5, Issue:1 Pt 2

    Topics: Blood; Glaucoma; Sulfanilamide; Sulfanilamides; Sulfonamides

1946
[On a new preparation with antiglaucomatous action: cardrase (6-ethoxy-2-benzothiazolosulfonamide)].
    Annali di ottalmologia e clinica oculistica, 1961, Volume: 87

    Topics: Carbonic Anhydrase Inhibitors; Ethoxzolamide; Glaucoma; Humans; Sulfanilamide; Sulfanilamides; Sulfo

1961